Major COVID-19 drugs trial begins in Birmingham

Posted on by

The NIHR Birmingham BRC has been working closely with a number of infrastructures in Birmingham, including University Hospitals Birmingham (UHB) and the Inflammation – Advanced and Cell Therapy Trials Team (I-ACT) at the University of Birmingham’s Cancer Research UK Clinical Trials Unit, to open a new drug trial for patients diagnosed with COVID-19.

You can read more on the University of Birmingham news page.